Articles tagged with: antiretrovirals

Re-evaluating my ability to work

published: July, 31, 2013 Written by // Wayne Bristow - Positive Life Categories // Aging, Finances, Lifestyle, Living with HIV, Wayne Bristow

Wayne Bristow and his thoughts on being on disability. Does he miss work? Could he ever go back again? And how does living on very limited income support affect him? Read on for the answers.

Re-evaluating my ability to work

"Sometimes we receive things in life that we didn’t choose, they chose us. It’s no surprise why my road wasn’t the bumpiest on my journey from being HIV-positive and working to HIV-positive and unable to work." Back in 2003 when I was diagnosed HIV-positive I had been at my job for over 20 years. I was earning nearly $25 per hour and had one hundred percent of my benefits paid. I was told I didn’t need to take medications right away, in fact my doctor said it might be ten years befo

Len Tooley on PrEP — Part Three

published: February, 27, 2013 Written by // John McCullagh - Publisher emeritus Categories // Activism, As Prevention , Gay Men, Mental Health, Features and Interviews, Sexual Health, Health, Treatment, Population Specific , Sex and Sexuality , John McCullagh

Len Tooley is an HIV-negative gay guy who is on pre-exposure prophylaxis. In this third of three interviews with PositiveLite.com, he responds to critics of negative guys who think PrEP is right for them.

Len Tooley on PrEP — Part Three

Len Tooley is a relatively young, HIV-negative gay guy who works in downtown Toronto as a gay men’s health promoter and an HIV educator, tester and counsellor. As a way of helping him stay HIV-negative, his family doctor prescribed him Truvada as pre-exposure prophylaxis (PrEP).  In the first part of his interview with me, which we published two weeks ago, Len talked about what motivated him to go on PrEP. Last week he discussed the conversations he had with his family doctor about PrE

Len Tooley on PrEP — Part Two

published: February, 20, 2013 Written by // John McCullagh - Publisher emeritus Categories // Activism, As Prevention , Gay Men, Mental Health, Features and Interviews, Sexual Health, Health, Treatment, Population Specific , Sex and Sexuality , John McCullagh

Len Tooley, an HIV-negative guy on pre-exposure prophylaxis, works as a gay men’s health promoter, HIV educator, tester and counsellor. In this second of three interviews, he talks about conversations with his doctor about PrEP and about being on it.

Len Tooley on PrEP — Part Two

Len Tooley is a 31-year old, sexually active, HIV-negative gay guy who lives in downtown Toronto, where he works as a gay men's health promoter, HIV educator, tester and counsellor. As a way of helping him stay HIV-negative, his family doctor has prescribed him Truvada as a pre-exposure prophylaxis (PrEP).  In the first part of his interview with me, which we published last week, Len and I talked about what motivated his decision to go on PrEP. This week, he discusses the conversations h

Len Tooley on PrEP — Part One

published: February, 13, 2013 Written by // John McCullagh - Publisher emeritus Categories // Activism, As Prevention , Gay Men, Mental Health, Features and Interviews, Sexual Health, Health, Treatment, Population Specific , Sex and Sexuality , John McCullagh

Len Tooley is an HIV-negative gay guy on pre-exposure prophylaxis who works in Toronto as a gay men’s health promoter, HIV educator, tester and counsellor. In the first of three interviews about being on PrEP, he discusses his decision to go on it.

Len Tooley on PrEP — Part One

In July 2012, the U.S. Food and Drug Administration (FDA) approved the use of Truvada (a fixed dose combination in one tablet of emtricitabine and tenofovir) to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. This use of an anti-HIV drug to prevent infection is known as pre-exposure prophylaxis (PrEP).  PrEP is considered by most observers to be a major breakthrough in

Moving research on new “biomedical” HIV prevention technologies into practice

published: December, 28, 2012 Written by // Guest Authors - Revolving Door Categories // As Prevention , CATIE, Sexual Health, Health, Revolving Door, Treatment, Guest Authors, Opinion Pieces

Guest writer CATIE’s James Wilton explores the challenges and opportunities in moving research around new HIV prevention technologies like treatment as prevention into practice

Moving research on new “biomedical” HIV prevention technologies into practice

This article first appeared on the website of Pacific AIDS Network here. Republished with permisision of the author. Folllow PAN on twitter at @PAN_CBR  Moving research on new “biomedical” HIV prevention technologies into practice By James Wilton Recent research findings have improved our understanding of HIV transmission and prevention and could change the landscape of our response to the HIV epidemic. In the past few years, several new HIV prevention approaches, such as post-exposure

The Promise and Risk of ‘Flushing’ Treatments

published: December, 27, 2012 Written by // Guest Authors - Revolving Door Categories // Research, Health, Revolving Door, Guest Authors, Living with HIV

Guest writer Jim Fox on research in to eradicating HIV from those reservoirs in our bodies where the virus hides

The Promise and Risk of ‘Flushing’ Treatments

Recent advances in a number of research fields, particularly the antiretrovirals (ARVs) have largely transformed HIV/AIDS from a painful death sentence to a manageable illness. And additional advances in peripheral fields like gene therapy, vaccines, cellular manipulation, etc., actually have immunologists and researches using the word “cure” without fear of being tagged as irresponsible pipe-dreamers. However, so far the hypothetical end-product of most of these research paths have been q

Antiretroviral therapy may be stabilising HIV epidemic in Danish gay men

published: June, 08, 2012 Categories // As Prevention , Research, Health, Revolving Door, Treatment, Guest Authors

New Danish research, aidsdmap reports, suggests stabilising of the epidemic in that country is due to antiretroviral therapy rather than changes in sexual behaviour

Antiretroviral therapy may be stabilising HIV epidemic in Danish gay men

This article by Michael Carter originally published by NAM/www.aidsmap.com is republished with permission. The use of antiretroviral treatment appears to have stabilised the HIV epidemic in Danish gay men, even though rates of risky sex have increased, research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests. “While unsafe sex among MSM [men who have sex with men] has increased substantially and the number of HIV-positive MSM living in Denma

BRIDGING the GAP: Barriers to HIV TREATMENT.

published: September, 06, 2011 Categories // Events, Upcoming Events, Health, Treatment, Events

Wednesday September 14th. Presentation 7 - 9 pm, Ramada Plaza Hotel.

BRIDGING the GAP: Barriers to HIV TREATMENT.

Wednesday September 14th. Presentation 7 - 9 pm. Light buffet 6:00pm.BRIDGING the GAP: Barriers to HIV TREATMENT.Ramada Plaza Hotel. 300 Jarvis Str.Toronto No registration required